Approval is based on multicohort trial, UTX-TGR-205.
-
-
The draft guidance is now open for public consultation until January 28, 2021, with the final guidance due next month.
-
NHS patients will be among the first in the world to be offered access to the CAR-T therapy.
-
Excerpts from an interview with a Harvard lymphoma specialist.
-
Investigators are hopeful of an approval.
-
The updated ESMO Clinical Practice Guidelines provide key recommendations on the management of follicular lymphoma
-
Dr. Zelenetz on an analysis of CIBMTR registry data at the NCCN Hematologic Malignancies Annual Congress.
-
Tazemetostat received accelerated FDA approval based on these findings.
-
The European Medicines Agency has recommended granting a licence for treatment with autologous anti-CD19-transduced CD3+ cell therapy.
-
Tafasitamab-cxix was recently approved by the US FDA.
-
Retrospective cohort study of more than 2 million in Korea uncovers association.
-
Session presented at ASH 2020.
-
Drug tested on DLBCL cell lines.
-
Polatuzumab vedotin with rituximab and bendamustine for relapsed or refractory diffuse large B-cell lymphoma